NCT02780375View on ClinicalTrials.gov

Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

July 17, 2018

Study Completion Date

July 17, 2018

Conditions
Cancer
Interventions
PROCEDURE

Blood donation during radiotherapy

Participants will be asked to donate a blood sample at 5 time points before and during their radiotherapy

Trial Locations (1)

SM2 5PT

The Royal Marsden, Sutton

All Listed Sponsors
collaborator

Public Health England

OTHER_GOV

lead

Institute of Cancer Research, United Kingdom

OTHER

NCT02780375 - Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects | Biotech Hunter | Biotech Hunter